-
QIMR Berghofer researchers create drugs for Covid-19
pharmaceutical-technology
May 26, 2021
Researchers from QIMR Berghofer Medical Research Institute in Queensland, Australia, have created two new peptide-based drugs to potentially prevent and treat Covid-19.
-
CaDi introduces Lycofertilic™ - high potency, targeted supplements with algae DHA Omega-3 to provide anti-ageing support for the ovarian reserve and to prepare for egg retrieval and IVF
prnasia
October 23, 2020
Cambridge Diagnostic Imaging (CaDi) is launching a new generation of targeted daily supplements, LycofertilicTM for fertility support and LycofertilicTM Prime to prepare for egg retrieval and IVF.
-
Emcure launches India first generic version of sucroferric oxyhydroxide for chronic kidney disease patients
expresspharma
July 02, 2020
Dynulta, the drug's brand name, will be manufactured at Emcure's state-of-the-art plant at Jammu and will be marketed at less than 70 per cent cost of the innovator brand.
-
EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations
en-cphi
April 23, 2020
EpimAb receives exclusive access to newly discovered target combinations in order to expand its proprietary pipeline
-
Ariel has lauched a series of high-quality products including formulas with Lactoferrin and integrated nutrition technology into daily life
prnasia
March 20, 2020
Recently, Ariel (an expert in mother and baby nutrition in Australia), a brand founded by Australia Origin Biotechnology PTY Ltd (OBP) that is specializing in nutritional supplement industry, has launched a series of high-quality products including formul
-
Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board
b3cnewswire
April 01, 2017
Dr. Claudia Roth, Vice President for Vetter’s department of Innovation Management, has been appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart.